NSF Considers Slashing Academic Salary Support

WASHINGTON—The National Science Foundation is considering a major policy change that would limit its payment of salaries to university researchers. The controversial idea, still under discussion, would bar the 20,000 senior investigators the foundation supports each year from receiving any more than summer salaries in their grants. NSF now spends $200 million annually, roughly 12% of its total research budget, on salaries to senior scientists. More than half of that amount gces to provid

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—The National Science Foundation is considering a major policy change that would limit its payment of salaries to university researchers. The controversial idea, still under discussion, would bar the 20,000 senior investigators the foundation supports each year from receiving any more than summer salaries in their grants.

NSF now spends $200 million annually, roughly 12% of its total research budget, on salaries to senior scientists. More than half of that amount gces to provide salaries for all or part of the academic year.

Dropping funds for academic-year salaries would free up scarce funds to support graduate students and postdoctoral researchers, say advocates of the change, which was discussed at last month’s meeting of the National Science Board, the foundation’s governing body. Such a policy, they note, would also send a message to universities that research is an integral part of many faculty members’ jobs and deserves to be supported to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies